CoinsAQ summary · neutral
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

What happened
ChatGPT maker OpenAI is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite of products.
Related asset context
Not financial advice. News and sentiment can be incomplete, delayed, or change quickly.



